These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...

Masimo backs FY24 EPS view $3.80-$4.00, consensus $3.88 Backs FY24 revenue view $2.085B-$2.135B, consensus $2.1B. Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

According to a regulatory filing, following a review by outside counsel, on October 24, 2024, the Board of Directors of Masimo (MASI) adopted ...

Medical-device maker said Joe Kiani, who previously informed the board of his decision to resign as chief executive, has been ...

Apple wins $250 from Masimo in its smartwatch patent infringement case, but the victory doesn’t change much in its larger ...

Masimo filed a lawsuit against its founder and former CEO Joe Kiani and investment firm RTW Investments, accusing them of ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Masimo (MASI) reports results for the quarter ended September 2024. While this widely-known consensus outlook is ...

Masimo (NASDAQ: MASI) today announced that Vanderbilt University Medical Center (VUMC), a renowned healthcare facility in ...

Apple has sought an injunction against health tech maker Masimo’s own smart watches, but it also netted the bare minimum for ...

The jury, in Delaware, agreed with Apple that previous iterations of Masimo’s W1 and Freedom watches and chargers willfully ...

A federal jury has found that Masimo smartwatches infringed on two of Apple's smartwatches, according to media reports.

Masimo Corp. is suing founder Joe Kiani—who lost a takeover fight last month against Politan Capital Management LP—saying he ...